Literature DB >> 35378990

Transcatheter Myotomy to Relieve Left Ventricular Outflow Tract Obstruction: The Septal Scoring Along the Midline Endocardium Procedure in Animals.

Jaffar M Khan1, Christopher G Bruce1, Adam B Greenbaum2, Vasilis C Babaliaros2, Andrea E Jaimes1, William H Schenke1, Rajiv Ramasawmy1, Felicia Seemann1, Daniel A Herzka1, Toby Rogers3, Michael A Eckhaus4, Adrienne Campbell-Washburn1, Robert A Guyton2, Robert J Lederman1.   

Abstract

BACKGROUND: Left ventricular outflow tract obstruction complicates hypertrophic cardiomyopathy and transcatheter mitral valve replacement. Septal reduction therapies including surgical myectomy and alcohol septal ablation are limited by surgical morbidity or coronary anatomy and high pacemaker rates, respectively. We developed a novel transcatheter procedure, mimicking surgical myotomy, called Septal Scoring Along the Midline Endocardium (SESAME).
METHODS: SESAME was performed in 5 naive pigs and 5 pigs with percutaneous aortic banding-induced left ventricular hypertrophy. Fluoroscopy and intracardiac echocardiography guided the procedures. Coronary guiding catheters and guidewires were used to mechanically enter the basal interventricular septum. Imparting a tip bend to the guidewire enabled intramyocardial navigation with multiple df. The guidewire trajectory determined the geometry of SESAME myotomy. The myocardium was lacerated using transcatheter electrosurgery. Cardiac function and tissue characteristics were assessed by cardiac magnetic resonance at baseline, postprocedure, and at 7- or 30-day follow-up.
RESULTS: SESAME myotomy along the intended trajectory was achieved in all animals. The myocardium splayed after laceration, increasing left ventricular outflow tract area (753 to 854 mm2, P=0.008). Two naive pigs developed ventricular septal defects due to excessively deep lacerations in thin baseline septa. No hypertrophy model pig, with increased septal thickness and left ventricular mass compared with naive pigs, developed ventricular septal defects. One animal developed left axis deviation on ECG but no higher conduction block was seen in any animal. Coronary artery branches were intact on angiography with no infarction on cardiac magnetic resonance late gadolinium imaging. Cardiac magnetic resonance chamber volumes, function, flow, and global strain were preserved. No myocardial edema was evident on cardiac magnetic resonance T1 mapping.
CONCLUSIONS: This preclinical study demonstrated feasibility of SESAME, a novel transcatheter myotomy to relieve left ventricular outflow tract obstruction. This percutaneous procedure using available devices, with a safe surgical precedent, is readily translatable into patients.

Entities:  

Keywords:  cardiomyopathy; catheter; electrosurgery; hypertrophy; myectomy

Mesh:

Year:  2022        PMID: 35378990      PMCID: PMC9232916          DOI: 10.1161/CIRCINTERVENTIONS.121.011686

Source DB:  PubMed          Journal:  Circ Cardiovasc Interv        ISSN: 1941-7640            Impact factor:   7.514


  22 in total

1.  Surgical treatment of idiopathic hypertrophic subaortic stenosis: technic and hemodynamic results of subaortic ventriculomyotomy.

Authors:  A G MORROW; E C BROCKENBROUGH
Journal:  Ann Surg       Date:  1961-08       Impact factor: 12.969

2.  Low Operative Mortality Achieved With Surgical Septal Myectomy: Role of Dedicated Hypertrophic Cardiomyopathy Centers in the Management of Dynamic Subaortic Obstruction.

Authors:  Barry J Maron; Joseph A Dearani; Steve R Ommen; Martin S Maron; Hartzell V Schaff; Rick A Nishimura; Anthony Ralph-Edwards; Harry Rakowski; Mark V Sherrid; Daniel G Swistel; Sandhya Balaram; Hassan Rastegar; Ethan J Rowin; Nicholas G Smedira; Bruce W Lytle; Milind Y Desai; Harry M Lever
Journal:  J Am Coll Cardiol       Date:  2015-09-15       Impact factor: 24.094

3.  Transcatheter Laceration of Aortic Leaflets to Prevent Coronary Obstruction During Transcatheter Aortic Valve Replacement: Concept to First-in-Human.

Authors:  Jaffar M Khan; Danny Dvir; Adam B Greenbaum; Vasilis C Babaliaros; Toby Rogers; Gabriel Aldea; Mark Reisman; G Burkhard Mackensen; Marvin H K Eng; Gaetano Paone; Dee Dee Wang; Robert A Guyton; Chandan M Devireddy; William H Schenke; Robert J Lederman
Journal:  JACC Cardiovasc Interv       Date:  2018-04-09       Impact factor: 11.195

Review 4.  Surgical treatment for hypertrophic cardiomyopathy: a historical perspective.

Authors:  Dustin Hang; Anita Nguyen; Hartzell V Schaff
Journal:  Ann Cardiothorac Surg       Date:  2017-07

5.  Opportunities in Interventional and Diagnostic Imaging by Using High-Performance Low-Field-Strength MRI.

Authors:  Adrienne E Campbell-Washburn; Rajiv Ramasawmy; Matthew C Restivo; Ipshita Bhattacharya; Burcu Basar; Daniel A Herzka; Michael S Hansen; Toby Rogers; W Patricia Bandettini; Delaney R McGuirt; Christine Mancini; David Grodzki; Rainer Schneider; Waqas Majeed; Himanshu Bhat; Hui Xue; Joel Moss; Ashkan A Malayeri; Elizabeth C Jones; Alan P Koretsky; Peter Kellman; Marcus Y Chen; Robert J Lederman; Robert S Balaban
Journal:  Radiology       Date:  2019-10-01       Impact factor: 11.105

6.  Antegrade Intentional Laceration of the Anterior Mitral Leaflet to Prevent Left Ventricular Outflow Tract Obstruction: A Simplified Technique From Bench to Bedside.

Authors:  John C Lisko; Adam B Greenbaum; Robert J Lederman; Vasilis C Babaliaros; Jaffar M Khan; Norihiko Kamioka; Patrick T Gleason; Isida Byku; Jose F Condado; Andres Jadue; Gaetano Paone; Kendra J Grubb; Jasleen Tiwana; James M McCabe; Toby Rogers
Journal:  Circ Cardiovasc Interv       Date:  2020-06-09       Impact factor: 6.546

Review 7.  Transcatheter Electrosurgery: JACC State-of-the-Art Review.

Authors:  Jaffar M Khan; Toby Rogers; Adam B Greenbaum; Vasilis C Babaliaros; Dursun Korel Yildirim; Christopher G Bruce; Daniel A Herzka; William H Schenke; Kanishka Ratnayaka; Robert J Lederman
Journal:  J Am Coll Cardiol       Date:  2020-03-31       Impact factor: 24.094

8.  Preventing Coronary Obstruction During Transcatheter Aortic Valve Replacement: Results From the Multicenter International BASILICA Registry.

Authors:  Jaffar M Khan; Vasilis C Babaliaros; Adam B Greenbaum; Christian Spies; David Daniels; Jeremiah P Depta; J Bradley Oldemeyer; Brian Whisenant; James M McCabe; Kamran I Muhammad; Isaac George; Paul Mahoney; Jonas Lanz; Roger J Laham; Pinak B Shah; Adnan Chhatriwalla; Shahram Yazdani; George Hanzel; Ashish Pershad; Robert A Leonardi; Ramzi Khalil; Gilbert H L Tang; Howard C Herrmann; Shikhar Agarwal; Peter S Fail; Ming Zhang; Andrei Pop; John Lisko; Emily Perdoncin; Rachel L Koch; Itsik Ben-Dor; Lowell F Satler; Cheng Zhang; Jeffrey E Cohen; Robert J Lederman; Ron Waksman; Toby Rogers
Journal:  JACC Cardiovasc Interv       Date:  2021-03-06       Impact factor: 11.195

Review 9.  2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

Authors:  Steve R Ommen; Seema Mital; Michael A Burke; Sharlene M Day; Anita Deswal; Perry Elliott; Lauren L Evanovich; Judy Hung; José A Joglar; Paul Kantor; Carey Kimmelstiel; Michelle Kittleson; Mark S Link; Martin S Maron; Matthew W Martinez; Christina Y Miyake; Hartzell V Schaff; Christopher Semsarian; Paul Sorajja
Journal:  Circulation       Date:  2020-11-20       Impact factor: 29.690

View more
  2 in total

Review 1.  Contemporary Therapies and Future Directions in the Management of Hypertrophic Cardiomyopathy.

Authors:  Elizabeth Packard; Alejandro de Feria; Supriya Peshin; Nosheen Reza; Anjali Tiku Owens
Journal:  Cardiol Ther       Date:  2022-10-15

2.  Transcatheter Myotomy to Treat Hypertrophic Cardiomyopathy and Enable Transcatheter Mitral Valve Replacement: First-in-Human Report of Septal Scoring Along the Midline Endocardium.

Authors:  Robert J Lederman; Vasilis C Babaliaros; Adam B Greenbaum; Jaffar M Khan; Christopher G Bruce; George S Hanzel; Patrick T Gleason; Keshav Kohli; Errol K Inci; Robert A Guyton; Gaetano Paone; Toby Rogers
Journal:  Circ Cardiovasc Interv       Date:  2022-05-23       Impact factor: 7.514

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.